These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25576088)

  • 21. The art of prescribing: pharmacological management of psychosis in Alzheimer's disease: clinical challenges associated with second-generation antipsychotic medications.
    Antai-Otong D
    Perspect Psychiatr Care; 2008 Apr; 44(2):120-3. PubMed ID: 18366366
    [No Abstract]   [Full Text] [Related]  

  • 22. Preferences of general practitioners and carers of Alzheimer patients regarding the use of neuroleptics for behavioural disorders in Alzheimer's disease.
    Gonzalez-Moneo MJ; Simó M; Pie M; Rivero D
    Int J Geriatr Psychiatry; 2008 Oct; 23(10):1095-7. PubMed ID: 18613282
    [No Abstract]   [Full Text] [Related]  

  • 23. 5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease.
    Engelborghs S; Holmes C; McCulley M; De Deyn PP
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1108-9. PubMed ID: 15497194
    [No Abstract]   [Full Text] [Related]  

  • 24. Alzheimer's disease and dementia.
    Geldmacher DS
    Clin Geriatr Med; 2004 Feb; 20(1):XI-XII. PubMed ID: 15062493
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs to treat Alzheimer's disease.
    J Psychosoc Nurs Ment Health Serv; 2014 Apr; 52(4):21-2. PubMed ID: 24694467
    [No Abstract]   [Full Text] [Related]  

  • 26. NIMH funds study of drugs for schizophrenia and Alzheimer's.
    J Psychosoc Nurs Ment Health Serv; 1999 Dec; 37(12):7. PubMed ID: 10618770
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
    Fan LY; Chiu MJ
    Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Alzheimer's disease: current and future therapeutic approaches.
    Cummings JL
    Rev Neurol Dis; 2004; 1(2):60-9. PubMed ID: 16400259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease.
    Petrie WM
    Compr Ther; 1985 Jul; 11(7):38-43. PubMed ID: 2863031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Alzheimer's disease therapies: focusing on the future. Proceedings of a symposium. November 7, 2001, Philadelphia, Pennsylvania, USA.
    Neurobiol Aging; 2002; 23(6):985-1105. PubMed ID: 12608384
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of psychotic symptoms in Alzheimer's patients.
    Ankenman R
    J Clin Psychiatry; 1990 Oct; 51(10):437-8. PubMed ID: 1976619
    [No Abstract]   [Full Text] [Related]  

  • 33. Alzheimer's disease.
    Maas ML; Buckwalter KC
    Annu Rev Nurs Res; 1991; 9():19-55. PubMed ID: 1756089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
    Grossman F; Okamoto A; Turkoz I; Gharabawi G
    J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
    [No Abstract]   [Full Text] [Related]  

  • 35. [Positive psychotic phenomena and Alzheimer's disease].
    von Gunten A
    Rev Med Suisse Romande; 1997 Nov; 117(11):865-70. PubMed ID: 9471650
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
    Omerovic M; Hampel H; Teipel SJ; Buerger K
    World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The translocator protein as a drug target in Alzheimer's disease.
    Chua SW; Kassiou M; Ittner LM
    Expert Rev Neurother; 2014 Apr; 14(4):439-48. PubMed ID: 24625007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical Alzheimer's disease therapeutics.
    Rafii MS
    J Alzheimers Dis; 2014; 42 Suppl 4():S545-9. PubMed ID: 25079804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comments on research in the social sciences pertaining to Alzheimer's disease: a more humble approach.
    Post SG
    Aging Ment Health; 2001 May; 5 Suppl 1():S17-9. PubMed ID: 11513492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agitation and aggression in people with Alzheimer's disease.
    Ballard C; Corbett A
    Curr Opin Psychiatry; 2013 May; 26(3):252-9. PubMed ID: 23528917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.